A personalized approach to acute myeloid leukemia therapy: current options

Therapeutic options for acute myeloid leukemia (AML) have remained unchanged for nearly the past 5 decades, with cytarabine and anthracyclines and use of hypomethylating agents for less intensive therapy. Implementation of large-scale genomic studies in the past decade has unraveled the genetic land...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmgenomics Pers Med
Asıl Yazarlar: Illangeswaran, Raveen Stephen Stallon, Das, Saswati, Paul, Daniel Zechariah, Mathews, Vikram, Balasubramanian, Poonkuzhali
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6684879/
https://ncbi.nlm.nih.gov/pubmed/31447578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S168267
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller